Christoph Thomas Ellebrecht, MD

Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737
Penn Medicine Provider

About me

  • Assistant Professor of Dermatology

My education and training

  • Medical School: Universitate Luebeck
  • Residency: University Hospital Schleswig-Holstein
  • Residency: Temple University Hospital
  • Residency: University of Pennsylvania Health System

Reviews

Average Rating

348 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
very thorough and knowledgeable
Anonymous
March 2026
dr Ellebrecht is a caring and knowledgeable doctor.
Anonymous
March 2026
very knowledgeable
Anonymous
February 2026
he knows my condition at a level of detail (and current clinical trials are underway) that i would expect of a leading dermatologist.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ellebrecht is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Caitlin S. Frazee, Sisi Chen, Corbett T. Berry, Casey S. Lee, Reid A. Banciella, Lucianna Ngo, David Shon, Patrick J. Herman, Jake S. Fischman, Chloe L. Leff, Anna Chen, Yvonne Kuo, Alexander A. Shestov, Andre R. Kelly, Bakir Valentic, Michael C. Milone, Roddy S. O'Connor, Christoph T. Ellebrecht Fate induction through asymmetric T cell division is modulated by chimeric antigen receptor co-stimulatory domains , Nature Immunology : 2026

Corbett T. Berry, Caitlin S. Frazee, Patrick J. Herman, Sisi Chen, Anna Chen, Yvonne Kuo, Christoph T. Ellebrecht Current advancements in cellular immunotherapy for autoimmune disease , Semin Immunopathol., 47(7): 2025

Christoph Ellebrecht, Aimee Payne Pemphigus , Fitzpatrick's Dermatology 10th edition: 2025

Lee CS, Chen S, Berry CT, Kelly AR, Herman PJ, Oh S, O'Connor RS, Payne AS, Ellebrecht CT Fate induction in CD8 CAR T cells through asymmetric cell division , Nature, 633: 2024,670–677

Corbett Berry, Casey Lee, Sisi Chen, Caitlin Frazee, Patrick Herman, Anna Chen, Andre Kelly, Roderick O'Connor, Christoph Ellebrecht Asymmetric epigenetic and metabolic remodeling of engineered CD4 T cells drives divergent cell fate , Society of Investigative Dermatology: 2024

Chat, Vipawee S., Ellebrecht, Christoph T., Kingston, Paige, Gondo, George, Bell, Stacie, Cordoro, Kelly M., Desai, Seemal R., Duffin, Kristina C., Feldman, Steven R., Garg, Amit, Gelfand, Joel M., Gladman, Dafna, Green, Lawrence J., Gudjonsson, Johann, Han, George, Hawkes, Jason E., Kircik, Leon, Koo, John, Langley, Richard, Lebwohl, Mark, Michael Lewitt, G., Liao, Wilson, Martin, George, Orbai, Ana-Maria, Reddy, Soumya M., Richardson, Veronica, Ritchlin, Christopher T., Schwartzman, Sergio, Siegel, Evan L., Van Voorhees, Abby S., Wallace, Elizabeth B., Weinberg, Jeffrey M., Winthrop, Kevin L., Yamauchi, Paul, Armstrong, April W. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation , Journal of the American Academy of Dermatology, 90((6):1170-1181.): 2024,1170-1181

Oh S, Mao X, Manfredo-Vieira S, Lee J, Patel D, Choi EJ, Alvarado A, Cottman-Thomas E, Maseda D, Tsao PY, Ellebrecht CT, Khella SL, Richman DP, O'Connor KC, Herzberg U, Binder GK, Milone MC, Basu S, Payne AS. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. , Nat Biotechnol. , 42(12): 2023,1923

Christoph T. Ellebrecht, Aimee S. Payne Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment , Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment, 1st Edition, McGraw Hill: 2023

Wat M, Mollanazar NK, Ellebrecht CT, Forrestel A, Elenitsas R, Chu EY. Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade. , J Cutan Pathol. , 49(11): 2022,978-987

Ellebrecht CT, Maseda D, Payne AS. Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways. , J Invest Dermatol. , 142(3): 2022,907-914

View all publications